Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
It is also associated with increased bone density and stronger structural support
Shafiei M, Ansari MNM, Razak SIA, Khan MUA
Front Oncol He YB, Fang LW, Hu D, Chen SL, Shen SY, Chen KL, Mu J, Li JY, Zhang H, Yong-Lin L et al (2022) Necroptosis-associated long noncoding RNAs can predict prognosis and differentiate between cold and hot tumors in ovarian cancer
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases